Vimarsana
Biggest News Aggregation in the World

Page 30 - Harbor Statement Under News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harbor Statement Under. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harbor Statement Under Today - Breaking & Trending Today

LARRY E. THOMPSON RE-ELECTED VICE CHAIR OF THE FEDERAL HOME LOAN BANK OF NEW YORK - Vimarsana News

LARRY E. THOMPSON RE-ELECTED VICE CHAIR OF THE FEDERAL HOME LOAN BANK OF NEW YORK

/PRNewswire/ -- The Federal Home Loan Bank of New York ("FHLBNY") announced today that Larry E. Thompson has been re-elected by its Board of Directors...

Bath & Body Works Reports Third Quarter Sales and Earnings Results - Vimarsana News

Bath & Body Works Reports Third Quarter Sales and Earnings Results

16.11.2022 - EPS of $0.40 Exceeds Guidance Range of $0.10 to $0.20COLUMBUS, Ohio, Nov. 16, 2022 (GLOBE NEWSWIRE) - Bath & Body Works, Inc. (NYSE: BBWI) today reported third quarter 2022 results. Sarah Nash, Executive Chair and Interim Chief Executive Officer, ...

FEDERAL HOME LOAN BANK OF NEW YORK DECLARES A 6.75% DIVIDEND FOR THE THIRD QUARTER OF 2022 - Vimarsana News

FEDERAL HOME LOAN BANK OF NEW YORK DECLARES A 6.75% DIVIDEND FOR THE THIRD QUARTER OF 2022

/PRNewswire/ -- The Federal Home Loan Bank of New York ("FHLBNY") is pleased to announce that, on November 17, 2022, its Board of Directors approved a dividend...

FEDERAL HOME LOAN BANK OF NEW YORK DECLARES A 6.75% DIVIDEND FOR THE THIRD QUARTER OF 2022 - Vimarsana News

FEDERAL HOME LOAN BANK OF NEW YORK DECLARES A 6.75% DIVIDEND FOR THE THIRD QUARTER OF 2022

/PRNewswire/ -- The Federal Home Loan Bank of New York ("FHLBNY") is pleased to announce that, on November 17, 2022, its Board of Directors approved a dividend...

Simulations Plus, Inc.: Simulations Plus and the University of Bath Awarded New FDA Grant - Vimarsana News

Simulations Plus, Inc.: Simulations Plus and the University of Bath Awarded New FDA Grant

Project will focus on the development of a modeling simulation framework to support an assessment of bioequivalence for locally-acting drugs in the gastrointestinal tract Simulations Plus, Inc.